Latha Palaniappan, MD, MS
Key Documents
Contact Information
-
Clinical Offices
PAMF - Internal Medicine 795 El Camino Real MC 5807 Palo Alto, CA 94301 Tel Work (650) 853-4752 Fax (650) 329-9114
- Academic Offices
Alternate Contact Ariel Holland Research Assistant Email Tel Work 650-853-2994Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Internal Medicine
Administrative Appointments
- Adjunct Clinical Assistant Professor, Stanford University School of Medicine (2006 - present)
- Associate Investigator, Palo Alto Medical Foundation Research Institute (2009 - present)
- Assistant Investigator, Palo Alto Medical Foundation Research Institute (2006 - 2009)
- Clinical Assistant Professor, University of California, San Francisco (2008 - present)
- Attending Physician, Preventive Cardiology Clinic (2002 - 2008)
Honors and Awards
- Fellow, American College of Physicians (2009)
- "Top Physician", ConsumersÂ’ Research Council of America (2007-2009)
- BIRCWH (Building Interdisciplinary Research Careers in WomenÂ’s Health) Scholar., NIH Career Development Award (K12) (2003 - 2006)
- Fellow, American College of Epidemiology (2003)
- Katherine McCormick Award, Stanford University (2003)
- Fellow, American Heart Association (2006)
Professional Education
| Residency: | Kaiser Found. Hosp. (San Fran) CA (07/99) |
| Medical Education: | University of Michigan School of Medicine MI (05/06/1996) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1999) |
| M.S.: | Stanford University, Epidemiology (2001) |
| B.A./M.D.: | University of Michigan, Integrated Premedical-Medical (1996) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Doctors Without Borders, East Timor
Internet Links
Scientific Focus
Current Research Interests
Latha Palaniappan is currently an Associate Investigator at the Palo Alto Medical Foundation Research Institute, an Adjunct Clinical Assistant Professor at Stanford University and Clinical Assistant Professor at the University of California San Francisco. Dr. Palaniappan has completed over 20 studies spanning 10 years in the areas of ethnicity, obesity, and diabetes risk. She has received grants from the General Clinical Research Center at the University of Michigan (MO1-RR00042) and the National Heart, Lung, and Blood Institute (Individual NIH National Research Service Award -
5F32HL010338) to explore gender and ethnic differences in insulin metabolism as it affects the incidence of metabolic syndrome and diabetes. She has explored these issues in clinical trials as well as in large national cohorts including the National Health and Nutrition Examination III (NHANES III)the Atherosclerosis Risk in Communities Study (ARIC) and the Insulin Resistance in Atherosclerosis Study(IRAS). Her clinical interests are in Preventive Cardiology, especially raising awareness of cardiovascular disease risk in Asian Americans. Dr. Palaniappan continues to devote 10% of her time to clinical practice in the Palo Alto Medical Foundation South Asian Wellness Program (www.pamf.org/prana). She has recently received research grants from the American Heart Association (0885049N) and the National Institutes of Health (1R01DK081371-01A1) to study cardiovascular disease and diabetes in Asian Americans.
Publications
- Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care. 2013; (5): 1215-21
- Shared medical appointments: promoting weight loss in a clinical setting. J Am Board Fam Med. 2011 May-Jun; (3): 326-8
- Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond). 2011; (3): 393-400
- Incorporation of whole, ancient grains into a modern Asian Indian diet to reduce the burden of chronic disease. Nutr Rev. 2011; (8): 479-88
- Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association. Circulation. 2010; (12): 1242-52
- Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population. J Diabetes Complications. 2013 Jan-Feb; (1): 34-40
Help